Chugai Financial Statements From 2010 to 2026
| CHGCF Stock | USD 52.48 2.43 4.43% |
Check Chugai Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chugai Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Chugai financial statements analysis is a perfect complement when working with Chugai Pharmaceutical Valuation or Volatility modules.
Chugai |
Chugai Pharmaceutical Co Company Operating Margin Analysis
Chugai Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Chugai Pharmaceutical Operating Margin | 0.42 % |
Most of Chugai Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Chugai Pharmaceutical Co has an Operating Margin of 0.4233%. This is 101.21% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 107.68% lower than that of the firm.
Chugai Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.Chugai Pharmaceutical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chugai Pharmaceutical Co is roughly 1.47 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chugai Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Chugai Pharmaceutical Financial Statements
Chugai Pharmaceutical stakeholders use historical fundamental indicators, such as Chugai Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Chugai Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chugai Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Chugai Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chugai Pharmaceutical Co. Please read more on our technical analysis and fundamental analysis pages.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Chugai Pink Sheet
Chugai Pharmaceutical financial ratios help investors to determine whether Chugai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chugai with respect to the benefits of owning Chugai Pharmaceutical security.